[44] first suggested that CREB1 is a downstream effector of miR‐450a mediating growth and metastatic traits in breast cancer cells, and that elevated CREB1 expression is associated with poor ER+ breast cancer prognosis. The gene discussed is CREB1; the disease is breast cancer.